Papers/PMID:36181086
The safety and efficacy of melatonin in the treatment of COVID-19: A systematic review and meta-analysis.
Medicine2022The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
melatonin — no detected effect on total leukocyte count
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“In the 3 studies, there was no significant difference in WBC count between the melatonin treated group and the control group (WMD = –1.07, 95% CI = –2.44, 0.30, P =.13) (Fig..”
Quoted verbatim from The safety and efficacy of melatonin in the treatment of COVID-19: A systematic review and meta-analysis.. - Study
- meta-analysis
- Population
- Hospitalised COVID-19 patients; secondary endpoint, 3 trials of adjunctive melatonin vs control
Effect -1.07 mean difference, 95% CI -2.44 to 0.3
The safety and efficacy of melatonin in the treatment of COVID-19: A systematic review and meta-analysis.2022PMID:36181086Permalink